ORBIMED ADVISORS LLC Insider Trading for September 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of ORBIMED ADVISORS LLC for September 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29 2017 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 28.25 | 672,000 | 18,984,000 | 4,129,638 | 4.8 M to 4.1 M (-14.00 %) |
| Sep 28 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 0.92 | 498 | 458 | 6,379 | 6.9 K to 6.4 K (-7.24 %) |
| Sep 28 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 0.92 | 52,301 | 48,117 | 669,914 | 722.2 K to 669.9 K (-7.24 %) |
| Sep 28 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.03 | 706 | 727 | 6,877 | 7.6 K to 6.9 K (-9.31 %) |
| Sep 28 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.03 | 74,096 | 76,319 | 722,215 | 796.3 K to 722.2 K (-9.30 %) |
| Sep 11 2017 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | X | 15.03 | 5,000 | 75,150 | 0 | |
| Sep 11 2017 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 22.35 | 5,000 | 111,750 | 4,801,638 | 4.8 M to 4.8 M (-0.10 %) |
| Sep 11 2017 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | X | 15.03 | 5,000 | 75,150 | 4,806,638 | 4.8 M to 4.8 M (+0.10 %) |
| Sep 05 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 40.77 | 553 | 22,546 | 7,895 | 8.4 K to 7.9 K (-6.55 %) |
| Sep 05 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 40.77 | 58,047 | 2,366,576 | 828,605 | 886.7 K to 828.6 K (-6.55 %) |
| Sep 05 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 39.63 | 1,808 | 71,651 | 8,448 | 10.3 K to 8.4 K (-17.63 %) |
| Sep 05 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 39.63 | 189,792 | 7,521,457 | 886,652 | 1.1 M to 886.7 K (-17.63 %) |
| Sep 05 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 37.94 | 1,651 | 62,639 | 10,256 | 11.9 K to 10.3 K (-13.87 %) |
| Sep 05 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 37.94 | 173,349 | 6,576,861 | 1,076,444 | 1.2 M to 1.1 M (-13.87 %) |
| Sep 05 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 37.72 | 1,038 | 39,153 | 11,907 | 12.9 K to 11.9 K (-8.02 %) |
| Sep 05 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 37.72 | 109,040 | 4,112,989 | 1,249,793 | 1.4 M to 1.2 M (-8.02 %) |
| Sep 05 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 37.82 | 424 | 16,036 | 12,945 | 13.4 K to 12.9 K (-3.17 %) |
| Sep 05 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 37.82 | 44,498 | 1,682,914 | 1,358,833 | 1.4 M to 1.4 M (-3.17 %) |